0000937556-24-000030.txt : 20240430 0000937556-24-000030.hdr.sgml : 20240430 20240430201111 ACCESSION NUMBER: 0000937556-24-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REYNOLDS CRAIG B CENTRAL INDEX KEY: 0001186476 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33642 FILM NUMBER: 24899467 MAIL ADDRESS: STREET 1: 1046 MIDDLEBROOK WAY CITY: KENESAW STATE: GA ZIP: 30144 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MASIMO CORP CENTRAL INDEX KEY: 0000937556 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330368882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-297-7000 MAIL ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1714522261.xml FORM 4 X0508 4 2024-04-26 0 0000937556 MASIMO CORP MASI 0001186476 REYNOLDS CRAIG B C/O MASIMO CORPORATION 52 DISCOVERY IRVINE CA 92618 1 0 0 0 1 Common Stock 2024-04-26 4 M 0 40000 23.04 A 47406 D Common Stock 2024-04-26 4 S 0 40000 136.1654 D 7406 D Non-Qualified Stock Option (Right to Buy) 23.04 2024-04-26 4 M 0 40000 0 D 2015-05-05 2024-05-05 Common Stock 40000 10000 D The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 17, 2023, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $135.46 per share to a high of $137.81 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on May 5, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. /s/ Micah W. Young, Attorney-In-Fact 2024-04-30